CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PharmaEssentia Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PharmaEssentia Corp
13F
No.3, Yuanqu Street, Nankang District.
Phone: +886 226557688p:+886 226557688 TAIPEI, 115  Taiwan Ticker: 64466446
Business Summary
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Pharmaceutical Officer Ching LeouTeng 9/24/2012 9/24/2012
Chief Executive Officer, Director Ko ChungLin 8/5/2021 6/25/2015
Senior Manager of Finance & Accounting, Corporate Governance Officer SnowChang 10/14/2015 10/14/2015
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Pharmaessentia USA Corporation 35 Corporate Drive Burlington MA United States

Business Names
Business Name
6446
Pharmaessentia USA Corporation

General Information
Number of Employees: 131 (As of 9/30/2015)
Outstanding Shares: 332,292,000 (As of 9/30/2024)
Shareholders: 37,712
Stock Exchange: TPE
Fax Number: +886 226557626


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024